| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.1M | — | -31.1% |
| Cost of Revenue | $1.9M | — | -33.3% |
| R&D Expense | $285K | — | +75.9% |
| SG&A Expense | $2.1M | — | +17.7% |
| Operating Income | -$3.0M | — | -18.2% |
| Pre-tax Income | -$3.0M | — | +7.8% |
| Net Income | -$3.3M | — | +24.7% |
| EPS (Basic) | -$18.08 | — | -623.2% |
| EPS (Diluted) | -$18.08 | — | -623.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.5M | +33.5% | +742.5% |
| Accounts Receivable | $4.8M | +33.0% | +10.6% |
| Inventory | $4.3M | +0.5% | +70.1% |
| Current Assets | $21.1M | +19.5% | +89.9% |
| Total Assets | $30.3M | +12.2% | +41.3% |
| Current Liabilities | $7.9M | +8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -4.3% |
| Capital Expenditures | $40K | — | +300.0% |
| Investing Cash Flow | -$47K | — | +20.3% |
| Financing Cash Flow | $5.5M | — | +2283.5% |
| Free Cash Flow | -$3.1M | — | -5.3% |
| -51.8% |
| Total Liabilities | $9.1M | +6.6% | -49.0% |
| Stockholders' Equity | $21.2M | +34.6% | +485.3% |